Navigation path

Conference Banner

Potential Use of Biomarkers of Inflammation and Early Immunological Events to Assess Vaccine Safety

10-11 May 2012, Baltimore

This meeting will bring together experts from the biological industry, academia and regulatory agencies to review the possibility of introducing new selected biomarkers in the assessment of vaccine safety at pre-clinical and early clinical stages (inflammation and early immunological events).

Further information

Themes

Health